HTGC vs JPC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HTGC presents a stark contrast between deep fundamental value and deteriorating financial health markers. While the Piotroski F-Score of 2/9 indicates weak operational health and the technical trend is bearish, the stock trades significantly below its Graham Number ($22.61) and Intrinsic Value ($54.58). Strong growth in revenue and earnings is offset by a concerning dividend payout ratio of 101.62%, suggesting the current yield is unsustainable. The valuation is highly attractive, but the deterministic health scores necessitate a cautious approach.
JPC exhibits a stable financial profile with a Piotroski F-Score of 6/9 and trades at a significant discount to its Graham Number of $12.82. While the fund shows strong historical performance (64.1% over 3 years) and a highly attractive P/E ratio of 8.82 compared to the sector average of 35.45, it is hampered by a bearish technical trend and weak insider sentiment. The valuation is anchored by a Price/Book ratio of 0.98, suggesting the asset is priced fairly relative to its net asset value, though the intrinsic growth-based value is lower at $6.30.
Compare Another Pair
Related Comparisons
HTGC vs JPC: Head-to-Head Comparison
This page compares Hercules Capital, Inc. (HTGC) and Nuveen Preferred & Income Opportunities Fund (JPC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.